Clinical Trial Details
EORTC-62072
Back to Clinical Trials Database
A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 01-Oct-2008 Date Step1 close: 08-Mar-2010 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized blind |
Targeted Sample size | All Groups: 255 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00794521 |
NCT number | NCT00794521 |
EudraCT | 2008-001307-33 |